Hasil Pencarian - Otto Metzger Filho

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma

    Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma oleh Felipe Ades, Otto Metzger-Filho

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications

    Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications oleh Romualdo Barroso-Sousa, Otto Metzger-Filho

    Diterbitkan 2016-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02)

    Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GB... oleh Arlindo R. Ferreira, Otto Metzger-Filho, Roberta M. B. Sarmento, José Bines

    Diterbitkan 2018-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Challenges in launching multinational oncology clinical trials in India

    Challenges in launching multinational oncology clinical trials in India oleh Kamal S Saini, Gaurav Agarwal, Ramesh Jagannathan, Otto Metzger-Filho, Monika L Saini, Khurshid Mistry, Raghib Ali, Sudeep Gupta

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

    Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial oleh Francesca Poggio, Lucia Del Mastro, Florentine S Hilbers, Saranya Chumsri, Noam F Pondé, Dominique Agbor-Tarh, Otto Metzger-Filho, Larissa A Korde, Olena Werner, Volker Moebus, Alvaro Moreno-Aspitia, Martine J Piccart

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Linfoma Não-Hodgkin de Alto Grau - Revisão da Literatura

    Linfoma Não-Hodgkin de Alto Grau - Revisão da Literatura oleh Luiz Henrique de Lima Araújo, Ana Paula Ornellas de Souza Victorino, Andréia Cristina de Melo, Daniele Xavier Assad, Danilo Silva Lima, Divaldo Rodrigues de Alencar, Melba Moura Lobo Moreira, Otto Metzger Filho, Rafaela de Faria de Souza Coelho, Selem Brandão Asmar, Bruno dos Santos Vilhena Pereira, Adriana Scheliga

    Diterbitkan 2008-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer

    The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer oleh Michalina Janiszewska, Shayna Stein, Otto Metzger Filho, Jennifer Eng, Natalie L. Kingston, Nicholas W. Harper, Inga H. Rye, Maša Alečković, Anne Trinh, Katherine C. Murphy, Elisabetta Marangoni, Simona Cristea, Benjamin Oakes, Eric P. Winer, Ian E. Krop, Hege G. Russnes, Paul T. Spellman, Elmar Bucher, Zhi Hu, Koei Chin, Joe W. Gray, Franziska Michor, Kornelia Polyak

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.

    Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer. oleh Otto Metzger-Filho, Aurélie Catteau, Stefan Michiels, Marc Buyse, Michail Ignatiadis, Kamal S Saini, Evandro de Azambuja, Virginie Fasolo, Sihem Naji, Jean Luc Canon, Paul Delrée, Michel Coibion, Pino Cusumano, Veronique Jossa, Jean Pierre Kains, Denis Larsimont, Vincent Richard, Daniel Faverly, Nathalie Cornez, Peter Vuylsteke, Brigitte Vanderschueren, Hélène Peyro-Saint-Paul, Martine Piccart, Christos Sotiriou

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness

    Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness oleh Otto Metzger-Filho, Katharine Collier, Sarah Asad, Peter J. Ansell, Mark Watson, Junu Bae, Mathew Cherian, Joyce O’Shaughnessy, Michael Untch, Hope S. Rugo, Jens B. Huober, Mehra Golshan, William M. Sikov, Gunter von Minckwitz, Priya Rastogi, Lang Li, Lijun Cheng, David Maag, Norman Wolmark, Carsten Denkert, W. Fraser Symmans, Charles E. Geyer, Sibylle Loibl, Daniel G. Stover

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: